For the year ending 2025-12-31, MAIA had -$943,267 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Loss on fair value of warrants over proceeds | 0 |
| Net loss | -22,396,172 |
| Stock-based compensation | 2,631,652 |
| Restricted shares issued for consulting and research expense | 618,813 |
| Change in fair value of warrant liability | -1,198,210 |
| Prepaid expenses and other current assets | 579,766 |
| Australia research and development incentives receivable | -80,410 |
| Accounts payable | 519,720 |
| Accrued expenses | 1,478,955 |
| Net cash used in operating activities | -18,844,598 |
| Proceeds from private placement-Private Placement Offering One Twenty Twenty Four | 0 |
| Proceeds from private placement-Private Placement Offering Two Twenty Twenty Four | 0 |
| Proceeds from private placement-Private Placement Offering Three Twenty Twenty Four | 0 |
| Proceeds from private placement-Private Placement Offering Four Twenty Twenty Four | 0 |
| Proceeds from private placement-Private Placement Offering Five Twenty Twenty Four | 0 |
| Proceeds from exercise of stock options | 844 |
| Proceeds from exercise of warrants | 901,578 |
| Proceeds from private placement-Private Placement Offering One Twenty Twenty Five | 2,715,000 |
| Proceeds from private placement-Private Placement Offering Two Twenty Twenty Five | 1,428,949 |
| Proceeds from private placement-Private Placement Offering Three Twenty Twenty Five | 1,079,998 |
| Proceeds from private placement-Private Placement Offering Four Twenty Twenty Five | 694,999 |
| Proceeds from private placement-Private Placement Offering Five Twenty Twenty Five | 2,253,900 |
| Proceeds from private placement-Private Placement Offering Six Twenty Twenty Five | 736,600 |
| Proceeds from private placement-Private Placement Offering Seven Twenty Twenty Five | 1,509,796 |
| Proceeds from at-the-market offering | 7,202,016 |
| Payment of offering transactions costs | 617,133 |
| Net cash provided by financing activities | 17,906,547 |
| Net effect of foreign currency exchange on cash | -5,216 |
| Net (decrease) increase in cash | -943,267 |
| Cash at beginning of period | 9,601,298 |
| Cash at end of period | 8,658,031 |
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)